JP2017518283A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017518283A5 JP2017518283A5 JP2016567727A JP2016567727A JP2017518283A5 JP 2017518283 A5 JP2017518283 A5 JP 2017518283A5 JP 2016567727 A JP2016567727 A JP 2016567727A JP 2016567727 A JP2016567727 A JP 2016567727A JP 2017518283 A5 JP2017518283 A5 JP 2017518283A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- symptoms
- images
- treatment
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000024891 symptom Diseases 0.000 claims description 70
- 208000017667 Chronic Disease Diseases 0.000 claims description 60
- 238000000034 method Methods 0.000 claims description 40
- 238000011282 treatment Methods 0.000 claims description 24
- 230000001815 facial effect Effects 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 7
- 230000001747 exhibiting effect Effects 0.000 claims description 7
- 208000014311 Cushing syndrome Diseases 0.000 claims description 6
- 201000009395 primary hyperaldosteronism Diseases 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 208000017701 Endocrine disease Diseases 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 5
- 208000030172 endocrine system disease Diseases 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 4
- 229960003248 mifepristone Drugs 0.000 claims description 4
- VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 claims description 4
- 206010040829 Skin discolouration Diseases 0.000 claims description 3
- 210000002468 fat body Anatomy 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 230000037370 skin discoloration Effects 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000012491 analyte Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 238000009534 blood test Methods 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 238000011269 treatment regimen Methods 0.000 claims description 2
- 206010061818 Disease progression Diseases 0.000 claims 1
- 230000005750 disease progression Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000007705 chemical test Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461994815P | 2014-05-16 | 2014-05-16 | |
| US61/994,815 | 2014-05-16 | ||
| PCT/US2015/031408 WO2015176062A2 (en) | 2014-05-16 | 2015-05-18 | Systems and methods of managing treatment of a chronic condition by symptom tracking |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019201529A Division JP2020023573A (ja) | 2014-05-16 | 2019-11-06 | 症状の追跡による慢性状態の治療を管理するシステムおよび方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017518283A JP2017518283A (ja) | 2017-07-06 |
| JP2017518283A5 true JP2017518283A5 (https=) | 2018-06-28 |
| JP6712233B2 JP6712233B2 (ja) | 2020-06-17 |
Family
ID=54480946
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567727A Expired - Fee Related JP6712233B2 (ja) | 2014-05-16 | 2015-05-18 | 症状の追跡による慢性状態の治療を管理するシステムおよび方法 |
| JP2019201529A Withdrawn JP2020023573A (ja) | 2014-05-16 | 2019-11-06 | 症状の追跡による慢性状態の治療を管理するシステムおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019201529A Withdrawn JP2020023573A (ja) | 2014-05-16 | 2019-11-06 | 症状の追跡による慢性状態の治療を管理するシステムおよび方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9977875B2 (https=) |
| EP (1) | EP3143494B1 (https=) |
| JP (2) | JP6712233B2 (https=) |
| CN (1) | CN106662992A (https=) |
| AU (1) | AU2015258807B2 (https=) |
| CA (1) | CA2948575C (https=) |
| ES (1) | ES2871089T3 (https=) |
| WO (1) | WO2015176062A2 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106662992A (zh) | 2014-05-16 | 2017-05-10 | 科赛普特治疗学股份有限公司 | 通过症状跟踪来管理慢性病症的治疗的系统和方法 |
| US11045134B2 (en) * | 2016-01-19 | 2021-06-29 | Washington University | Depression brain computer interface for the quantitative assessment of mood state and for biofeedback for mood alteration |
| US12096308B2 (en) | 2016-12-15 | 2024-09-17 | Conquer Your Addiction Llc | Systems and methods for conducting/defending digital warfare or conflict |
| US11412353B2 (en) | 2016-12-15 | 2022-08-09 | Conquer Your Addiction Llc | Systems and methods for monitoring for and preempting the risk of a future occurrence of a quarantine violation |
| US10853897B2 (en) | 2016-12-15 | 2020-12-01 | David H. Williams | Systems and methods for developing, monitoring, and enforcing agreements, understandings, and/or contracts |
| US11636941B2 (en) | 2016-12-15 | 2023-04-25 | Conquer Your Addiction Llc | Dynamic and adaptive systems and methods for rewarding and/or disincentivizing behaviors |
| US10497242B2 (en) | 2016-12-15 | 2019-12-03 | David H. Williams | Systems and methods for monitoring for and preempting pre-identified restriction violation-related behavior(s) of persons under restriction |
| US12342240B2 (en) | 2016-12-15 | 2025-06-24 | Conquer Your Addiction Llc | Systems and methods for monitoring for and lowering the risk of addiction-related or restriction violation-related behavior(s) |
| WO2018112048A1 (en) | 2016-12-15 | 2018-06-21 | Williams David H | Systems and methods for providing location-based security and/or privacy for restricting user access |
| US12470894B2 (en) | 2016-12-15 | 2025-11-11 | Conquer Your Addiction Llc | Systems and methods for proactively preempting/mitigating anxiety-related behaviors and associated issues/events |
| JP2021520982A (ja) * | 2018-02-19 | 2021-08-26 | ジェイソン ハリソン，ハワード | 医療診断用の画像収集および寸法分析のための方法及びシステム |
| JP7230409B2 (ja) * | 2018-10-02 | 2023-03-01 | カシオ計算機株式会社 | 判定装置、判定方法及び判定プログラム |
| US11728031B2 (en) | 2018-10-12 | 2023-08-15 | Bfc Med Llc | Software application for patient care and related device, system, and method |
| CN110473629A (zh) * | 2019-08-22 | 2019-11-19 | 南京航空航天大学 | 一种肾透析治疗方案推荐方法及系统 |
| JP7419720B2 (ja) * | 2019-09-24 | 2024-01-23 | カシオ計算機株式会社 | 画像処理装置、画像処理方法及び画像処理プログラム |
| CN111493585A (zh) * | 2020-04-24 | 2020-08-07 | 王晨庄 | 基于5g智能化的多用途综合远控床医疗体和智能方法 |
| US11504048B2 (en) | 2020-06-10 | 2022-11-22 | Medtronic Monitoring, Inc. | Triggering arrhythmia episodes for heart failure and chronotropic incompetence diagnosis and monitoring |
| US20230267612A1 (en) * | 2020-08-14 | 2023-08-24 | Sanofi | A monitoring system |
| CN112489746B (zh) * | 2020-12-08 | 2024-07-05 | 深圳平安智慧医健科技有限公司 | 数据管理的任务推送方法、装置、电子设备及存储介质 |
| KR102510347B1 (ko) * | 2021-02-10 | 2023-03-20 | 고려대학교 산학협력단 | 위암 수술 이후 제2형 당뇨병 예후의 예측 방법 |
| US12009103B1 (en) * | 2021-03-04 | 2024-06-11 | Edward R Silansky | Systems, devices, and/or methods for managing health |
| JP7135146B1 (ja) * | 2021-03-26 | 2022-09-12 | エヌ・ティ・ティ・コミュニケーションズ株式会社 | 投薬対象者管理システム、管理方法、管理制御装置、端末装置およびプログラム |
| US20230060942A1 (en) * | 2021-08-26 | 2023-03-02 | Hypatia Group, Inc. | Health Monitoring System with Precision Eye-Blocking Filter |
| US20230381527A1 (en) * | 2022-05-31 | 2023-11-30 | West Affum Holdings Dublin DAC | Wearable medical system with device parameters and patient information programmable via browser interface |
| CN117809857B (zh) * | 2024-02-29 | 2024-06-07 | 广州市品众电子科技有限公司 | 一种基于人工智能的vr设备运行数据分析方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008210399A (ja) * | 1997-03-14 | 2008-09-11 | First Opinion Corp | 疾患管理システム |
| JP2004065822A (ja) | 2002-08-09 | 2004-03-04 | Nippon Colin Co Ltd | 遠隔診断システム |
| US20050283385A1 (en) * | 2004-06-21 | 2005-12-22 | The Permanente Medical Group, Inc. | Individualized healthcare management system |
| US20060036619A1 (en) * | 2004-08-09 | 2006-02-16 | Oren Fuerst | Method for accessing and analyzing medically related information from multiple sources collected into one or more databases for deriving illness probability and/or for generating alerts for the detection of emergency events relating to disease management including HIV and SARS, and for syndromic surveillance of infectious disease and for predicting risk of adverse events to one or more drugs |
| US20080242977A1 (en) * | 2007-03-30 | 2008-10-02 | General Electric Company | Systems, methods and apparatus for longitudinal/temporal analysis of plaque lesions |
| US10776453B2 (en) * | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
| EP3607942B1 (en) * | 2008-11-07 | 2025-10-01 | University of Sheffield | Medicament and method of diagnosis |
| WO2012093363A2 (en) | 2011-01-07 | 2012-07-12 | Koninklijke Philips Electronics N.V. | Integrated access to and interation with multiplicity of clinica data analytic modules |
| CN102063579A (zh) * | 2011-01-30 | 2011-05-18 | 潘亚萍 | 牙周电子病历系统及其操作方法 |
| CN102231172A (zh) * | 2011-06-10 | 2011-11-02 | 王坦 | 一种远程医疗信息采集系统 |
| US20130006793A1 (en) * | 2011-06-29 | 2013-01-03 | International Business Machines Corporation | Migrating Computing Environment Entitlement Contracts Based on Seller and Buyer Specified Criteria |
| US10500216B2 (en) | 2011-11-18 | 2019-12-10 | Corcept Therapeutics, Inc. | Optimizing mifepristone absorption |
| US9836581B2 (en) * | 2012-08-16 | 2017-12-05 | Ginger.io, Inc. | Method for modeling behavior and health changes |
| CN103324853A (zh) * | 2013-06-25 | 2013-09-25 | 上海交通大学 | 基于医学图像特征的相似度计算系统及方法 |
| AU2014321267A1 (en) | 2013-09-20 | 2016-05-05 | Corcept Therapeutics, Inc. | Systems and methods of treatment using intervention and tasking determination |
| CN103690149B (zh) | 2013-12-30 | 2016-08-17 | 惠州Tcl移动通信有限公司 | 通过面部拍照识别身体健康状况的移动终端及其实现方法 |
| CN106662992A (zh) | 2014-05-16 | 2017-05-10 | 科赛普特治疗学股份有限公司 | 通过症状跟踪来管理慢性病症的治疗的系统和方法 |
-
2015
- 2015-05-18 CN CN201580037068.XA patent/CN106662992A/zh active Pending
- 2015-05-18 US US14/715,311 patent/US9977875B2/en active Active
- 2015-05-18 AU AU2015258807A patent/AU2015258807B2/en not_active Ceased
- 2015-05-18 ES ES15793415T patent/ES2871089T3/es active Active
- 2015-05-18 JP JP2016567727A patent/JP6712233B2/ja not_active Expired - Fee Related
- 2015-05-18 WO PCT/US2015/031408 patent/WO2015176062A2/en not_active Ceased
- 2015-05-18 CA CA2948575A patent/CA2948575C/en active Active
- 2015-05-18 EP EP15793415.9A patent/EP3143494B1/en active Active
-
2018
- 2018-04-16 US US15/954,262 patent/US11610666B2/en active Active
-
2019
- 2019-11-06 JP JP2019201529A patent/JP2020023573A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017518283A5 (https=) | ||
| Reiffel et al. | Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: the REVEAL AF study | |
| Limpawattana et al. | Sarcopenia in chronic obstructive pulmonary disease: a study of prevalence and associated factors in the Southeast Asian population | |
| Ryerson et al. | Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study | |
| Frasure-Smith et al. | Depression and other psychological risks following myocardial infarction | |
| JP6712233B2 (ja) | 症状の追跡による慢性状態の治療を管理するシステムおよび方法 | |
| Weiss et al. | Low tidal volume ventilation use in acute respiratory distress syndrome | |
| Lee et al. | Event-free survival in adults with heart failure who engage in self-care management | |
| Moler et al. | Multicenter cohort study of out-of-hospital pediatric cardiac arrest | |
| Colilla et al. | Estimates of current and future incidence and prevalence of atrial fibrillation in the US adult population | |
| Leiva-Fernández et al. | Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial | |
| Ice et al. | Risk factors for dexmedetomidine-associated hemodynamic instability in noncardiac intensive care unit patients | |
| Warren et al. | Adrenaline (epinephrine) dosing period and survival after in-hospital cardiac arrest: a retrospective review of prospectively collected data | |
| Yen et al. | Atrial fibrillation and coronary artery disease as risk factors of retinal artery occlusion: a nationwide population‐based study | |
| Runte et al. | Hemodynamic changes during physiological and pharmacological stress testing in healthy subjects, aortic stenosis and aortic coarctation patients–a systematic review and meta-analysis | |
| Flæten et al. | Incidence, characteristics, and associated factors of pressure injuries acquired in intensive care units over a 12-month period: A secondary analysis of a quality improvement project | |
| Ferrández et al. | Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period | |
| Fouche et al. | Frequency of adjustment with comorbidity and illness severity scores and indices in cardiac arrest research | |
| MacDonald et al. | Cardiovascular autonomic function and incident chronic obstructive pulmonary disease hospitalizations in atherosclerosis risk in communities | |
| Kušleikaitė et al. | The association between health-related quality of life and mortality among hemodialysis patients | |
| Serhal et al. | Integrating pharmacy and registry data strengthens clinical assessments of patient adherence | |
| Jayaprakash et al. | Improving diagnostic fidelity: an approach to standardizing the process in patients with emerging critical illness | |
| Randolph et al. | Randomized clinical trials in pediatric critical care: Rarely done but desperately needed | |
| Abid et al. | Chest pain assessment and imaging practices for nurse practitioners in the emergency department | |
| Opielinski et al. | COVID-19 and the impact of physical activity on persistent symptoms |